SurgeryCOLSOSNCT05147623
Colombian Surgical Outcomes Study - COLSOS
An observational study of Surgery and Postoperative Complications, run by Fundación Cardioinfantil Instituto de Cardiología at 2 sites in Colombia.
Trial summary
An observational, analytical, multicentre prospective cohort study will be conducted throughout Colombia. A sample size of 1353 patients is needed to achieve significance in our primary objective; however, convenience sampling is considered, as we aim to include all the institutions and patients possible. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Surgery, Postoperative Complications, Hospital Mortality
- What is being tested?
- Any surgery/procedure
- Type of treatment
- Surgery or procedure
- How many people
- 1,353 participants
- Where
- 2 sitesColombia
- Study dates
- 16 Nov 2021to 22 May 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: All patients of legal age who underwent to surgical procedures by the participating institutions in the data collection period will be included.
Who may be able to join
- Patients over 18 years of age.
- Ones who underwent to a surgical intervention in the collection period, by the participating institutions.
- Both public and private institutions will be included.
- Patients with and without COVID-19 infection will be included.
Who cannot join
- Patients who do not have the necessary clinical records to complete the information during data collection.
- Patients who do not approve inclusion in the study through informed consent.
- The following shall be excluded:
- Procedures that were performed outside of operating rooms.
- Radiological procedures.
- Endoscopic procedures.
Trial locations and contacts
2 sites in 1 country.
Colombia2 sites
Fundación Cardioinfantil Instituto de Cardiología
Bogotá, Cundinamarca, 101101
Clínica Avidanti
Ibague, Tolima Department
About this study
Official title: Postoperative Mortality in Colombia: Perspectives of the Fourth Indicator in The Lancet Commission on Global Surgery (Colombian Surgical Outcomes Study)
An observational, analytical, multicentre prospective cohort study will be conducted throughout Colombia. A sample size of 1353 patients is needed to achieve significance in our primary objective; however, convenience sampling is considered, as we aim to include all the institutions and patients possible. The data collection will be carried out prospectively for one week, and all patients will have a follow-up of a maximum of 30 days in-hospital. The primary outcome will be to determine the in-hospital mortality. We aim to contribute with accurate information on in-hospital postoperative mortality in Colombia. Thus, by following precisely the instructions created by The Lancet Commission on Global Surgery. The data obtained will help formulate public policies in the surgical field adjusted to the Colombian population, improving the quality of the surgical divisions in the different Colombian institutions, positively affecting the attention and development of the Colombian healthcare system.
Read the detailed description
The general objective of this research is to describe the in-hospital postoperative mortality of patients who have had surgical procedures in Colombian institutions.
We also aim to characterize the sociodemographic and clinical variables of the patients that underwent a surgical procedure in Colombia, determine the secondary postoperative clinical outcomes associated with surgical procedures in Colombia and illustrate the installed surgical capacity and infrastructure of the participating health centres.
The study will be carried out throughout Colombia. The largest number possible of institutions in which surgeries are performed will be included. We expect to have at least 2 or 3 institutions per region. We currently have 65 confirmed participating institutions and have conducted a preliminary interaction with 257 institutions throughout the territory. The list of participating centres and researchers will be continuously updated, and the final version of the list will be attached to the final report.
A sample size estimate of 1353 patients was made to establish the lower limit needed to achieve significance in our primary objective. The estimate was made with the postoperative mortality rate in Colombia obtained in the study by Hanna et al. of 0.74% (13), an alpha value of 0.05, an accuracy of 0.5%, and a design effect of 1.2. Also, due to the nature of the study, it is not possible to randomize. Nevertheless, convenience sampling is considered, as we aim to include all the patients possible.
A descriptive analysis of the data will be performed. The continuous variables will be assessed whit normality tests (Shapiro Wilk or Kolmogorov Smirnov). If the variables have a normal distribution, they will be expressed as mean (measure of central tendency) and as standard deviation (measure of dispersion). Contrariwise, if the variables have a non-normal distribution, they will be expressed as median (measure of central tendency) and as interquartile range (measure of dispersion).
The continuous data with normal distribution will be studied with parametric tests according to the number of comparators: we will use the student t-test or ANOVA if a comparison of more than two groups is required. For continuous data with non-normal distribution, non-parametric tests will be used: if two groups are compared, we will use the Mann Whitney test, and between three groups, the Kruskal Wallis test. The P-value shall be considered statistically significant < 0,05. Categorical variables shall be presented with absolute frequencies and proportions. Categorical data will be compared between two groups using the Chi-square test or fisher's test at convenience to obtain data after collection.
Logistic regression will be carried out multilevel by individual, city or municipality, department, and country. It will evaluate the association between risk factors and primary outcomes and adjust for differences in confounding factors. A multivariate logistic model will be created for specific mortality comparisons that include all potential risk factors associated with in-hospital mortality. The possible risk factors variables with a variance inflation factor more significant than two were excluded to avoid collinearity.
Four strategies are proposed to attract interested researchers and institutions to participate in this study. Because of the support of the Colombian Surgical Association through the official mail of the organization, a generalized invitation will be sent to all clinics and hospitals with surgical processes, throughout the country, with general information of the research study to attract interest from these institutions. Additionally, the journal and website of the Colombian Surgical Association in both the journal and on the website of the society of general surgery the registration will be published so students, interns, doctors, residents, and specialists interested in participating. Finally, voice-to-voice communication and mass dissemination through ColombianSurg Collaborative social networks (Instagram, Twitter, Facebook, and Official Website) cannot be ruled out.
Coordination with institutions and departments: A hierarchical management organization was set up to generate specific and personalized attention to each region and institution (Figure 3). In addition, researchers will be able to communicate with the ColombianSurg Collaborative team and vice versa through different platforms that will be put at their services, such as instant messaging groups, email, and official Websites.
- Conditions
- Surgery, Postoperative Complications, Hospital Mortality
- Being tested
- Any surgery/procedure
- Keywords
- Hospital mortality, Postoperative complications, Surgery, Public Health
- Medical subject headings
- Postoperative Complications
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Any surgery/procedureProcedure or surgery
Any surgery/procedure in all adult patients that were performed in an operating room
| Study group | Role | What they receive |
|---|---|---|
| Principal cohort | All patients recruited in one week who underwent to any surgical procedure that meet inclusion criteria of the study. Receives: Procedure: Any surgery/procedure |
What is being measured
The primary outcome is the main question the study is designed to answer.
In-hospital postoperative mortality
In-hospital postoperative mortality of patients who have had surgical procedures in Colombian institutions.
Measured: 30 days
Secondary outcomes (1)
Postoperative complications
Early complications related to surgical procedures that occurred in the selected patients
Measured: 30 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Dec 2021
- Study start16 Nov 2021
- Primary completion16 May 2022 (estimated)
- Study completion22 May 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for SurgeryStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1,353 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Fundación Cardioinfantil Instituto de Cardiología
- Sponsor type
- University, hospital or other
- Collaborators
- Universidad del Rosario
- Responsible party
- Sponsor
- Investigators
- Paulo A. Cabrera, MD, MSc, Principal investigator, Fundación Cardioinfantil Instituto de CardiologíaCarlos J. Perez, MD, MSc, Principal investigator, Fundación Cardioinfantil Instituto de Cardiología
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05147623
- Sponsor's protocol ID
- 2021-PRO-CAR-1538
- Acronym
- COLSOS
- Status last verified
- Nov 2021
- First submitted
- 24 Nov 2021
- Last updated
- 7 Dec 2021
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: The data will be collected and stored online through the server Research Electronic Data Capture(Redcap) web application. Redcap allows collaborators to enter data and store it in a security system. The designated collaborator of each hospital will receive the login data in the Redcap system (login), so that the data is sent securely to the server. Only anonymous data will be uploaded to the database. No data will be collected to identify patients. The points of adherence to the STROBE statement have been respected for the study design.
Publications
Perez-Rivera CJ, Lozano-Suarez N, Velandia-Sanchez A, Polania-Sandoval CA, Garcia-Mendez JP, Idarraga-Ayala SV, Corso-Ramirez JM, Conde-Monroy D, Cruz-Reyes DL, Duran-Torres CF, Barrera-Carvajal JG, Rojas-Serrano LF, Garcia-Zambrano LA, Agudelo-Mendoza SV, Briceno-Ayala L, Cabrera-Rivera PA; ColombianSurg Collaborative. Perioperative mortality in Colombia: perspectives of the fourth indicator in The Lancet Commission on Global Surgery - Colombian Surgical Outcomes Study (ColSOS) - a protocol for a multicentre prospective cohort study. BMJ Open. 2022 Nov 30;12(11):e063182. doi: 10.1136/bmjopen-2022-063182.
PubMed 36450427
Study at a glance
From the registry record, last updated by the sponsor on 7 Dec 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Postoperative Mortality in Colombia: Perspectives of the Fourth Indicator in The Lancet Commission on Global Surgery (Colombian Surgical Outcomes Study)
- ClinicalTrials.gov ID
- NCT05147623
- Acronym / sponsor ID
- COLSOS / 2021-PRO-CAR-1538
- Conditions
- Surgery, Postoperative Complications, Hospital Mortality
- Keywords
- Hospital mortality, Postoperative complications, Surgery, Public Health
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,353 participants (estimated)
- Lead sponsor
- Fundación Cardioinfantil Instituto de CardiologíaUniversity, hospital or other
- Collaborators
- Universidad del Rosario
- Study start
- 16 Nov 2021 (actual)
- Primary completion
- 16 May 2022 (estimated)
- Study completion
- 22 May 2023 (estimated)
- First posted
- 7 Dec 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
An observational, analytical, multicentre prospective cohort study will be conducted throughout Colombia. A sample size of 1353 patients is needed to achieve significance in our primary objective; however, convenience sampling is considered, as we aim to include all the institutions and patients possible. The data collection will be carried out prospectively for one week, and all patients will have a follow-up of a maximum of 30 days in-hospital. The primary outcome will be to determine the in-hospital mortality. We aim to contribute with accurate information on in-hospital postoperative mortality in Colombia. Thus, by following precisely the instructions created by The Lancet Commission on Global Surgery. The data obtained will help formulate public policies in the surgical field adjusted to the Colombian population, improving the quality of the surgical divisions in the different Colombian institutions, positively affecting the attention and development of the Colombian healthcare system.
Detailed description
The general objective of this research is to describe the in-hospital postoperative mortality of patients who have had surgical procedures in Colombian institutions.
We also aim to characterize the sociodemographic and clinical variables of the patients that underwent a surgical procedure in Colombia, determine the secondary postoperative clinical outcomes associated with surgical procedures in Colombia and illustrate the installed surgical capacity and infrastructure of the participating health centres.
The study will be carried out throughout Colombia. The largest number possible of institutions in which surgeries are performed will be included. We expect to have at least 2 or 3 institutions per region. We currently have 65 confirmed participating institutions and have conducted a preliminary interaction with 257 institutions throughout the territory. The list of participating centres and researchers will be continuously updated, and the final version of the list will be attached to the final report.
A sample size estimate of 1353 patients was made to establish the lower limit needed to achieve significance in our primary objective. The estimate was made with the postoperative mortality rate in Colombia obtained in the study by Hanna et al. of 0.74% (13), an alpha value of 0.05, an accuracy of 0.5%, and a design effect of 1.2. Also, due to the nature of the study, it is not possible to randomize. Nevertheless, convenience sampling is considered, as we aim to include all the patients possible.
A descriptive analysis of the data will be performed. The continuous variables will be assessed whit normality tests (Shapiro Wilk or Kolmogorov Smirnov). If the variables have a normal distribution, they will be expressed as mean (measure of central tendency) and as standard deviation (measure of dispersion). Contrariwise, if the variables have a non-normal distribution, they will be expressed as median (measure of central tendency) and as interquartile range (measure of dispersion).
The continuous data with normal distribution will be studied with parametric tests according to the number of comparators: we will use the student t-test or ANOVA if a comparison of more than two groups is required. For continuous data with non-normal distribution, non-parametric tests will be used: if two groups are compared, we will use the Mann Whitney test, and between three groups, the Kruskal Wallis test. The P-value shall be considered statistically significant < 0,05. Categorical variables shall be presented with absolute frequencies and proportions. Categorical data will be compared between two groups using the Chi-square test or fisher's test at convenience to obtain data after collection.
Logistic regression will be carried out multilevel by individual, city or municipality, department, and country. It will evaluate the association between risk factors and primary outcomes and adjust for differences in confounding factors. A multivariate logistic model will be created for specific mortality comparisons that include all potential risk factors associated with in-hospital mortality. The possible risk factors variables with a variance inflation factor more significant than two were excluded to avoid collinearity.
Four strategies are proposed to attract interested researchers and institutions to participate in this study. Because of the support of the Colombian Surgical Association through the official mail of the organization, a generalized invitation will be sent to all clinics and hospitals with surgical processes, throughout the country, with general information of the research study to attract interest from these institutions. Additionally, the journal and website of the Colombian Surgical Association in both the journal and on the website of the society of general surgery the registration will be published so students, interns, doctors, residents, and specialists interested in participating. Finally, voice-to-voice communication and mass dissemination through ColombianSurg Collaborative social networks (Instagram, Twitter, Facebook, and Official Website) cannot be ruled out.
Coordination with institutions and departments: A hierarchical management organization was set up to generate specific and personalized attention to each region and institution (Figure 3). In addition, researchers will be able to communicate with the ColombianSurg Collaborative team and vice versa through different platforms that will be put at their services, such as instant messaging groups, email, and official Websites.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Principal cohort | – | Procedure: Any surgery/procedureAll patients recruited in one week who underwent to any surgical procedure that meet inclusion criteria of the study. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- All patients of legal age who underwent to surgical procedures by the participating institutions in the data collection period will be included.
Key inclusion criteria (4 listed)
- Patients over 18 years of age.
- Ones who underwent to a surgical intervention in the collection period, by the participating institutions.
- Both public and private institutions will be included.
- Patients with and without COVID-19 infection will be included.
Key exclusion criteria (6 listed)
- Patients who do not have the necessary clinical records to complete the information during data collection.
- Patients who do not approve inclusion in the study through informed consent.
- The following shall be excluded:
- Procedures that were performed outside of operating rooms.
- Radiological procedures.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Any surgery/procedureAny surgery/procedure in all adult patients that were performed in an operating room | Procedure or surgery | Principal cohort |
Primary outcome
In-hospital postoperative mortality
Time frame: 30 days
In-hospital postoperative mortality of patients who have had surgical procedures in Colombian institutions.
1 secondary outcome
Postoperative complications
Time frame: 30 days
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Dec 2021.
- Derived from this study: PubMed 36450427Perez-Rivera CJ, Lozano-Suarez N, Velandia-Sanchez A, Polania-Sandoval CA, Garcia-Mendez JP, Idarraga-Ayala SV, Corso-Ramirez JM, Conde-Monroy D, Cruz-Reyes DL, Duran-Torres CF, Barrera-Carvajal JG, Rojas-Serrano LF, Garcia-Zambrano LA, Agudelo-Mendoza SV, Briceno-Ayala L, Cabrera-Rivera PA; ColombianSurg Collaborative. Perioperative mortality in Colombia: perspectives of the fourth indicator in The Lancet Commission on Global Surgery - Colombian Surgical Outcomes Study (ColSOS) - a protocol for a multicentre prospective cohort study. BMJ Open. 2022 Nov 30;12(11):e063182. doi: 10.1136/bmjopen-2022-063182.
- Individual participant dataSharing planned: No. The data will be collected and stored online through the server Research Electronic Data Capture(Redcap) web application. Redcap allows collaborators to enter data and store it in a security system. The designated collaborator of each hospital will receive the login data in the Redcap system (login), so that the data is sent securely to the server. Only anonymous data will be uploaded to the database. No data will be collected to identify patients. The points of adherence to the STROBE statement have been respected for the study design.
Related trials for Surgery
RecruitingPhase 4
Anrikefon-based Patient-controlled Intravenous Analgesia Following Laparoscopic Surgery
Laparoscopic Surgery, Visceral Pain, Postoperative
RecruitingPhase 1
Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma
Adrenocortical Carcinoma (ACC), Recurrent Adrenocortical Carcinoma (ACC)
Not yet recruitingObservational study
Arterial Stiffness During Negative Pressure Wound Therapy for Abdominal Wall Wounds
Postoperative Abdominal Wall Wound Complications, Surgical Wound Infection
Recruiting
Safety and Performance of a Pelvic Floor Mesh Implant for Laparoscopic Sacrocolpopexy (ProGYNious)
Pelvic Organ Prolapse (POP), Synthetic Mesh
Active, not recruitingPhase 2
Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation
Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Paulo A. Cabrera, MD, MSc principal investigator
Fundación Cardioinfantil Instituto de Cardiología
Carlos J. Perez, MD, MSc principal investigator
Fundación Cardioinfantil Instituto de Cardiología
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Surgery and Postoperative Complications, run by Fundación Cardioinfantil Instituto de Cardiología at 2 sites in Colombia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 7 Dec 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Colombia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
In-hospital postoperative mortality (time frame: 30 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05147623, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Dec 2021.